CBLL (CeriBell) Stock Based Compensation: $13.60 Mil (TTM As of Mar. 2026)


CBLL CeriBell Inc CBLL
12 GF Score
Price $19.93
! 4 Warning Signs
View Full Analysis

What is CeriBell Stock Based Compensation?

CeriBell CBLL +1.37% 12 Stock Based Compensation is $13.60 Mil as of Mar. 2026. GuruFocus rates CBLL with a GF Score™ of 12/100. The stock has 4 warning signs investors should review.

CeriBell's Stock Based Compensation for the three months ended in Mar. 2026 was $3.72 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was $13.60 Mil.

CeriBell Stock Based Compensation Related Terms

CeriBell Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for CeriBell's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CeriBell Stock Based Compensation Chart

CeriBell Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
7.93 2.68 5.41 12.22

CeriBell Quarterly Data
Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.35 3.17 3.35 3.36 3.72
CBLL
12GF Score
CeriBell Inc CBLL
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CeriBell Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $13.60 Mil.

What does a Stock Based Compensation of $13.60 Mil mean?
CeriBell (CBLL) has a Stock Based Compensation of $13.60 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for CeriBell and its competitors.
Is CeriBell's Stock Based Compensation too high?
CeriBell's current Stock Based Compensation is $13.60 Mil. Overall, CeriBell has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does CeriBell's Stock Based Compensation compare to BBNX and SIBN?
CeriBell's Stock Based Compensation of $13.60 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Devices & Instruments company?
A good Stock Based Compensation depends on the Medical Devices & Instruments industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for CeriBell and its competitors. CeriBell's current Stock Based Compensation is $13.60 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CeriBell stock overvalued right now?
CeriBell (CBLL) has a current Stock Based Compensation of $13.60 Mil. The current Stock Based Compensation is $13.60 Mil. CeriBell's overall GF Score™ is 12/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For CeriBell (CBLL), the current Stock Based Compensation is $13.60 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CeriBell Business Description

Address 360 N. Pastoria Avenue, Sunnyvale, CA, USA, 94085
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.
12GF Score

Get the complete analysis for CBLL

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.93
Price